Cite Filings / SPRY / 0000947871-24-000710
Feed Companies Filings Check
Sign in
144

Sale of Securities

ARS Pharmaceuticals, Inc. · Filed 2024-08-21 · Acc 0000947871-24-000710

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-09-10 144 Sale of Securities
  • 2024-08-21 4 Chief Commercial Officer sold 10,000 shares at $14.00 ($140,000)
  • 2024-08-21 4 Chief Financial Officer sold 12,500 shares at $16.00 ($200,000)
  • 2024-08-21 4 CHIEF MEDICAL OFFICER sold 100,000 shares at an average $15.03 ($1,502,587)
  • 2024-08-21 4 PRESIDENT AND CEO sold 100,000 shares at an average $15.03 ($1,502,587)
  • 2024-08-21 144 Sale of Securities
  • 2024-08-20 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…